BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Sciwind Biosciences Announces Publication of Discovery, Preclinical, and Phase 1 Clinical Trial Results of Ecnoglutide (XW003) in Molecular Metabolism

  Sciwind Biosciences Co., Ltd. announced the publication of discovery, preclinical characterization, and Phase 1 clinical trial results of its GLP-1 analog ecnoglutide in Molecular Metabolism.

  July 11, 2023

   · 

  2 min read
• NUS and PwC Jointly Release Sustainability Counts II, affirming Fosun International’s leading standard in ESG disclosure

  The National University of Singapore Centre for Governance and Sustainability and PricewaterhouseCoopers Singapore recently jointly released Sustainability Counts II.

  July 11, 2023

   · 

  9 min read
• Latest data on lecanemab to be presented at Alzheimer’s Association International Conference (AAIC) 2023

  BioArctic AB’s partner Eisai will present the latest findings on lecanemab, an anti-amyloid beta protofibril antibody for the treatment of Alzheimer’s disease, at the Alzheimer’s Association International Conference.

  July 11, 2023

   · 

  6 min read